Contingency Management Programs: Incentive-Based Addiction Treatment

Paying People to Stay Sober Works

Contingency management (CM) is the most effective behavioral treatment for stimulant use disorder. It works on a straightforward principle: reward positive behavior. Patients receive incentives, often gift cards or vouchers, for providing drug-free urine samples, attending therapy sessions, or meeting other treatment goals. The approach has the strongest evidence base of any behavioral intervention for cocaine and methamphetamine addiction.

In January 2025, SAMHSA increased the annual incentive cap from $75 to $750 per person for programs operating under federal grants. This tenfold increase signals growing federal support for CM as a frontline treatment tool.

Critical Updates for 2025

SAMHSA raised the federal grant incentive cap from $75 to $750 per person per year
Five states (California, Delaware, Hawaii, Montana, Washington) have approved Medicaid coverage for CM
California launched the first statewide Medicaid-funded CM pilot program
Michigan announced a Recovery Incentives Pilot for Medicaid beneficiaries in 2024
CM is the only behavioral treatment with strong evidence for stimulant use disorder

Why Contingency Management Works

Addiction changes the brain’s reward system. Substances hijack the natural dopamine pathways that motivate behavior. CM addresses this directly by providing an alternative source of reward. When a patient earns a $15 gift card for a clean drug test, the brain registers a positive outcome tied to abstinence rather than substance use.

Research consistently shows CM improves outcomes across multiple substance use disorders.

Higher rates of abstinence during treatment
Longer treatment retention
Fewer missed appointments
Improved engagement with other therapeutic services

“Contingency management has the strongest evidence base of any behavioral intervention for stimulant use disorders. The increase in the incentive cap removes a significant barrier to effective implementation.” — Addiction Policy Forum, 2025

State-by-State Medicaid Coverage

The Centers for Medicare and Medicaid Services (CMS) allows states to cover CM services through Section 1115 demonstration waivers. As of January 2025, five states have received federal approval.

California was the first state to receive approval in late 2021. Its statewide pilot program targets stimulant use disorder and provides a model for other states. Delaware, Hawaii, Montana, and Washington have followed with their own approved waivers.

Washington State is actively rolling out CM benefits, with provider applications accepted through 2025 and sites expected to be operational by mid-2026. Kentucky announced in late 2025 a funding opportunity to launch CM pilot programs starting in early 2026.

Two additional states had waiver requests pending federal review as of January 2025.

Other Funding Sources for CM Programs

States and providers do not have to rely solely on Medicaid waivers. Multiple federal funding streams support CM implementation.

State Opioid Response (SOR) Grants from SAMHSA
Substance Use Prevention, Treatment, and Recovery Services Block Grants
Opioid Settlement Funding from pharmaceutical lawsuits
Title IV-E Prevention Service Program Funds

Finding a CM Program Near You

If you or a loved one is struggling with stimulant addiction, ask your treatment provider about contingency management. Not every program offers CM, but availability is growing rapidly with expanded funding. Look for programs that combine CM with cognitive behavioral therapy or other evidence-based approaches for the most comprehensive care. Treatment that rewards your progress works.